{"schema_version":"secwatch.filing_event.v1","accession":"0001846253-24-000071","form_type":"8-K","ticker":"OABI","cik":"0001846253","company_name":"OmniAb, Inc.","filed_at":"2024-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.878483+00:00","generated_at":"2026-05-31T11:17:12.767523+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"OmniAb Q2 revenue $7.6M, net loss $0.13/sh; guides 2024 opex slightly below 2023","bullets":["Q2 2024 revenue $7.6M (+10% YoY), net loss $13.6M ($0.13/sh) vs $14.7M loss in Q2 2023.","H1 2024 revenue $11.4M vs $23.9M (prior year included $10M TECVAYLI milestone); net loss $32.6M ($0.32/sh).","Cash $57.2M at June 30; expects 2024 opex slightly below 2023, cash use similar to 2023 ex-$35M milestone.","New platform licenses with DAAN Bio, Topaz Therapeutics, HanAll Biopharma; post-Q2 deals with 92Bio and Memorial Sloan Kettering.","GSK discontinued Nav1.1 program (OmniAb retains co-ownership); Roche returning Kv7.2 rights (not due to scientific reasons)."],"urls":{"canonical":"https://secwatch.observer/filing/0001846253-24-000071","json":"https://secwatch.observer/filing/0001846253-24-000071.json","markdown":"https://secwatch.observer/filing/0001846253-24-000071.md","text":"https://secwatch.observer/filing/0001846253-24-000071.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1846253/000184625324000071/0001846253-24-000071-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1846253/000184625324000071/oabi-20240808.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T11:17:12.767523+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}